QCM immunoassay for recombinant cysteine peptidase: A potential protein biomarker for diagnosis of citrus canker  by Afonso, André S. et al.
Talanta 104 (2013) 193–197Contents lists available at SciVerse ScienceDirectTalanta0039-91
http://d
n Corr
E-mjournal homepage: www.elsevier.com/locate/talantaShort communicationQCM immunoassay for recombinant cysteine peptidase: A potential protein
biomarker for diagnosis of citrus cankerAndre´ S. Afonso a,c, Bianca F. Zanetti b, Adelita C. Santiago b, Flavio Henrique-Silva b,
Luiz H.C. Mattoso c, Ronaldo C. Faria a,n
a Departamento de Quı´mica, Universidade Federal de S ~ao Carlos, CP 676, 13565-905, S~ao Carlos, SP, Brazil
b Departamento de Gene´tica e Evoluc- ~ao, Universidade Federal de S ~ao Carlos, CP 676, 13565-905, S ~ao Carlos, SP, Brazil
c EMBRAPA Instrumentac- ~ao Agropecua´ria, CP 741, 13560-970, S ~ao Carlos, SP, Brazila r t i c l e i n f o
Article history:
Received 25 September 2012
Received in revised form
1 November 2012
Accepted 3 November 2012
Available online 13 November 2012
Keywords:
Biomarker
Citrus canker
Citrus disease
Cysteine peptidase
Immunosensor
QCM40/$ - see front matter & 2012 Elsevier B.V. A
x.doi.org/10.1016/j.talanta.2012.11.003
esponding author. Tel.: þ55 16 3351 8084; fa
ail address: rcfaria@ufscar.br (R.C. Faria).a b s t r a c t
Citrus canker is one of the most important agricultural citrus diseases worldwide. It is caused by
Xanthomonas citri subsp. citri (Xcc) bacterium that infects leaves and the fruits produce a cysteine
peptidase (CPXaC), which makes it a potential target for the development of effective and rapid
detection methods for citrus canker. We report here the studies on the development of piezoelectric
immunoassay for CPXaC using a polyclonal antibody against CPXaC (anti-CPXaC). Three different
strategies for covalent immobilization of anti-CPXaC on gold surfaces were evaluated by monitoring the
frequency (Df) and energy dissipation (DD) variation in real time when 64.5108 mol L1 CPXaC was
added. Anti-CPXaC immobilized with 11-mercaptoundecanoic acid (MUA) showed the best relation
between the frequency and dissipation factor variation, and strong values for the kinetic and
equilibrium binding constant were obtained. The immunosensor showed a detection limit of
13.0 nmol L1 with excellent speciﬁcity, showing no response for different proteins that include
another cysteine peptidase that is used as a target to detect Xylella fastidiosa bacterium, responsible for
another important citrus disease. These results provide good perspectives for the use of CPXaC as a new
biomarker for citrus canker.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Citrus canker is one of the high economic impact diseases
affecting citrus species worldwide. It is caused by Xanthomonas
citri subsp. citri (Xcc), a gram-negative bacterium and is charac-
terized by conspicuous, erumpent lesions on leaves, stems, and
fruits [1]. The disease can cause defoliation, blemished fruit,
premature fruit drop, and tree decline [2]. There is no cure or
treatment for citrus canker, so once the infected trees are
detected, the surrounding symptomless trees must be destroyed
to avoid further infections that could result in high economic
losses [3]. The disease exists in more than 30 countries, therefore
the efforts to control and eradicate the infected areas and to
maintain canker-free areas are economically important for the
citrus market [4]. Conventional methods as polymerase chain
reaction (PCR), spectral information divergence classiﬁcation
methods, and laser induced ﬂuorescence spectroscopy have been
used for citrus canker detection; however they are time consuming,
labor intensive, expensive and require expertise [4–6]. A realizablell rights reserved.
x: þ55 16 3351 8053.expectation to prevent and control the new infections could be
offered by the early detection of citrus canker, coupled with
strategies to prevent its further spread. Thus, the use of immuno-
sensors for the detection of protein biomarkers emerges as an
alternative assay for simple, accurate and cost effective citrus canker
diagnosis.
The dissipation factor of a quartz crystal microbalance (QCM-D)
is a known high-sensitive technique that quantiﬁes and monitors
in real-time mass changes on the surface of a piezoelectric quartz
crystal [7]. QCM-D also has the capability to monitor the energy
dissipation (D-factor) that can be correlated with the ﬁlms’
viscoelasticity property. In this case, if a soft layer is deposited on
a crystal surface the shift in the resonance frequency does not
necessarily correspond only to the amount of mass adsorbed, but
also to the viscoelasticity variation on the layer [8]. Thus, the
D-factor could be used to compare different tailored surfaces for
the development of sensors. So the best strategy for sensor design
is related not only to the maximum resonance frequency variation
but also to the lowest variation in the dissipation factor (D) for a
same amount of analyte added to the sensors [9–12].
It has recently been demonstrated that phytopathogenic
bacteria includes the genus Xanthomonas [13] that uses a cysteine
peptidase to change plant physiology and which is related to
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produced by Xcc (CPXaC) is probably involved in the invasion
processes of the host, which then makes a potential protein
biomarker for the development of effective and rapid diagnosis
methods for the detection of citrus canker. In this paper we
describe for the ﬁrst time the development of a label-free QCM-D
immunosensor for CPXaC detection using an anti-CPXaC immo-
bilized on a crystal surface using different self-assembled mono-
layer (SAM) strategies. The piezoelectric immunoassay developed
showed high sensitive and selective real-time responses for
CPXaC. This approach opens the door to use CPXaC as a potential
protein biomarker for simple, low-cost, and fast immunoassay for
citrus canker detection.2. Experimental
The reagents, apparatus, the expression and puriﬁcation of
recombinant cysteine peptidase, polyclonal antibody and the immu-
nosensor construction are described in detail in the supplementary
materials. Three anti-CPXaC immobilization procedures on the gold
surface of the quartz were evaluated as follows: Immobilization
procedure 1 (IP1): The polyclonal anti-CPXaC was immobilized in
11-mercaptoundecanoic acid (MUA); Immobilization procedure 2
(IP2): The polyclonal anti-CPXaC was immobilized in a mixture
(1:10) of MUA and 6-mercapto-1-hexanol (MHO); Immobilization
procedure 3 (IP3): anti-CPXaC was immobilized using cystamine
(Cyst). Fig. 1 shows the immobilization procedures studied (for more
details see supplementary materials). All procedures were evaluated
based on resonance frequency variation as well as variation in
dissipation D-factor for antigen–antibody interaction to achieve the
best response for CPXaC.3. Results and discussion
3.1. Anti-CPXaC immobilization on crystal surface
Three different anti-CPXaC immobilization procedures on the
crystal surface were evaluated by real-time monitoring of Df and
DD variation. For this the modiﬁed piezoelectric crystal sensor
was inserted into a ﬂow cell, and pH 7.2 phosphate saline (PBS)
buffer (0.01 mol L1 phosphate, 0.15 mol L1 NaCl) was pumped,
and after the frequency was stabilized, CPXaC in PBS was injected.
Fig. 2 shows the variation of the third harmonic resonance
frequency and dissipation factor as a function of time for the
injection of 64.5108 mol L1 CPXaC to three different anti-
CPXaC modiﬁed crystals. When CPXaC was added, the reso-
nance frequency decreased for all modiﬁed crystals due to theFig. 1. Schematic showing the procedures IP1, IP2, and IP3 used for anti-CPXaC
immobilization on gold surface of the quartz crystal.
Fig. 2. Real-time variation of De (A) and DD (B) when 64.5108 mol L1 CPXaC
was added into QCM-D cell (C) DD/De plots for added 64.5108 mol L1 CPXaC
into QCM-D obtained from (A) and (B). Piezoelectric immunosensors were
constructed using three different procedures IP1, IP2 and IP3.antigen–antibody binding process. The largest shift in resonance
frequency was observed for crystals modiﬁed with MUA/MHO
(IP2) and MUA (IP1) and the lowest for IP3 that used Cyst SAM
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MHO was employed as a way to avoid steric hindrance for the
antibody–antigen interaction in the crystal surface in order to
improve the binding process [14]. Comparing the immobilization
procedures with and without MHO (IP1 and IP2) it was observed
(Fig. 2(A)) that the presence of MHO led to the highest Df, about
70% more than that in the absence of MHO, indicating that thus
far the use of a MUA/MHO mixture is a more efﬁcient immobi-
lization procedure for CPXaC binding. The crystal modiﬁed by IP3
showed the lowest Df probably due to the chemical modiﬁcation
of the antibody with EDC/NHS in solution, which can lead to
antibody–antibody bonding formation, hence decreasing the
number of free paratopes. On the other hand, IP3 showed the
lowest DD variation when CPXaC was added to the cell. The
crystal modiﬁed with IP3 presented a DD of 0.1106, followed
by 0.93106 for MUA, and 3.8106 for MUA/MHO (Fig. 2(B)).
The small variation in the D-factor for the sensor modiﬁed with
IP3 indicated that the ﬁlm formed after the binding process is
more rigidly coupled to the crystal when compared with MUA/
MHO and MUA. The immobilization procedures using MUA/MHO
and MUA show a higher variation in DD when CPXaC was
injected, indicating that the antigen–antibody interaction
resulted in a change in the viscoelastic properties of the ﬁlm
[15,16]. Fig. 2(C) presents the DD vs De plots obtained from the
data in Fig. 2(A and B) and the slopes, Kn, indicated different
relaxation times during the binding processes [17]. The immuno-
sensors showed distinguishable kinetic processes with three, two
and one slopes for MUA/MHO, MUA, and Cyst, respectively, as
summarized in Table 1. In all cases K1 presents small and very
similar values, indicating that the kinetic of the antigen–antibody
binding is fast, leading to the mass increased of the ﬁlm; however
the ﬁlm retains its rigidity as conﬁrmed by the tiny variation in
D-factor. The sensor developed by the IP3 procedure presents
only the K1 slope, which can be associated to the binding
processes with practically no variation in the viscoelastic proper-
ties, hence indicating a good correlation between frequency
variation and the mass uptake, according to the Sauerbrey
equation. However the variation in frequency obtained using IP3
procedure was quite small for analytical purposes. MUA/MHO and
MUA immobilization procedures showed small values for DD/Df
immediately after the addition of CPXaC; however for MUA/MHO
DD/Df change rapidly to high values (K2) and when the frequency
variation reaches about 10 Hz, DD/Df increased again, indicating
conformational changes in the antigen–antibody binding process
(K3). Although anti-CPXaC immobilization procedure based on the
use of MUA/MHO showed the highest Df value when CPXaC was
added, a large shift in the dissipation factor was observed,
indicating that the variation in frequency can be attributed not
only to the antigen mass uptake but also to conformational
changes and/or water trapped in the ﬁlm [15–17]. However, the
sensor constructed using MUA presents the smallest variation in
DD/Df indicating a more rigid and compact layer that can be
ascribed to antigen–antibody interaction. Considering our ﬁnd-
ings, further studies were carried out using IP1 based on MUA.Table 1
Values of DD/Df for the different immobilization procedures obtained from Fig. 2.
Immobilization procedure
DD/Df (106 Hz1) IP1 (MUA) IP2 (MUA/MHO) IP3 (Cyst)
K1 0.05 0.08 0.07
K2 0.17 0.28 –
K3 – 0.41 –The ﬁlm obtained by IP1 was characterized by PM-IRRAS and
contact angle, more details can be obtained in the SI.
3.2. Immunosensor development
After the best procedure for anti-CPXaC immobilization was
determined, the analytical curve was obtained by recording the Df
after adding different CPXaC concentrations into the QCM-D cell,
followed by a CPXaC-free PBS injection, Fig. 3(A and B). As can be
seen, when the antigen concentration raised, Df increased and a
linear shift was observed in the concentration range studied,
exhibiting a limit of detection of 13.0 nmol L1 based on signal-
to-noise ratio (S/N) of three, with a correlation coefﬁcient of
0.973. At the same time, variation in D-factor was evaluated after
the injection of different concentrations of CPXaC. The lowest DD
variation means that the ﬁlm is rigid, thus frequency response can
be well described by the Sauerbrey equation [18]. Thus, lower DD
values we obtained with procedure IP1, suggesting a rigid and
compact ﬁlm in the concentration range used, as shown inFig. 3. (A) Real-time curves of frequency variation for different CPXaC concentra-
tions from 0 to 64.5108 mol L1 of CPXaC (curves 1–5) injected in continuous
ﬂux of PBS buffer pH 7.2. (B) Analytical curve for CPXaC immunosensor.
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function of CPXaC concentration showed low and constant values
indicating that the stiffer protein layer was obtained after antigen
and antibody (see Fig. S-2 in supplementary materials).
3.3. Kinetics and association equilibrium constants
The determination of afﬁnity constant is important to evaluate
the feasibility of the antibody used for biosensor applications. The
equilibrium and kinetics constants were evaluated by measuringTable 2
Kinetic and equilibrium constants for CPXaC obtained from QCM analysis.
Method ka (L mol
1 s1) kd (s
1) Ka (L mol
1)
Method I – – 1.670.2106
Method II 7.870.2104 2.170.3102 3.670.3106
Fig. 4. (A) Real-time frequency variation when (curves 1 and 2) 32 and
64.5108 mol L1 CPXaC were injected into the cell with crystal modiﬁed
without antibody, and (curve 3) 32108 mol L1 CPXaC added into the cell
with piezoelectric crystal modiﬁed with attached antibody. (B) (curve 1) addition
of 4.15106 mol L1 canecystatin and (curve 2) addition of 3.03106 mol L1
BSA and (curve 3) addition of 32.0108 mol L1 of X. fastidiosa cysteine
peptidase to a crystal with immobilized anti-CPXaC.the shift in frequency when different concentrations of CPXaC
were added to the quartz crystal with the immobilized anti-
CPXaC using two methods, as previously reported [11,19]:Method
I: used the variation between initial and ﬁnal frequency and
Langmuir Isotherm model to obtain the association binding
constant, Ka, and Method II: used the frequency decreasing in real
time to obtain the binding and dissociation kinetic constants, ka
and kd respectively. A detailed description of binding constant
calculations is included in the supplementary materials. Table 2
presents the association constants calculated by both procedures,
which showed values as high as those observed for other antigen–
antibody binding processes [20,21] indicating that anti-CPXaC is a
good candidate for developing citrus canker immunoassays.3.4. Speciﬁcity study
The immunosensor speciﬁcity was evaluated by modifying the
gold surface using procedure IP1 but without the addition of
antibody. Only the blocked skim milk solution was added and
then exposed to a CPXaC solution in concentrations of 32.0 and
64.5108 mol L1. Fig. 4(A) shows frequency shift when CPXaC
was injected to a crystal without anti-CPXaC (curves 1 and 2) and
with immobilized anti-CPXaC (curve 3). In the absence of anti-
CPXaC, a shift in frequency was observed when CPXaC was added;
however after it was washed with PBS buffer, the frequency
returned to the initial values, indicating non-speciﬁc binding. The
speciﬁcity of the sensor was checked against different proteins,
such as canecystatin [22], BSA, and a cysteine peptidase that is a
target for the detection of Xylella fastidiosa, a gram-negative
bacterium responsible for citrus variegated chlorosis (CVC), which
is another important citrus disease [23]. The sensors were
exposed to solutions of 4.15106 mol L1 of canecystatin or
3.03106 mol L1 of BSA or 32.0108 mol L1 of X. fastidiosa
cysteine peptidase, the results are in Fig. 4(B). As can be seen, no
detectable signal was observed for the non-target proteins indi-
cating that developed piezoelectric sensor had good selectivity
and speciﬁcity for CPXaC from Xcc.4. Conclusions
We have presented the development of a piezoelectric immu-
nosensor for CPXaC detection using anti-CPXaC, produced in
rabbits, immobilized on a gold crystal surface. The CPXaC-anti-
CPXaC interaction studies showed good values for kinetic and
afﬁnity constants. The immunosensor showed stable and biocom-
patible selective interface with non-speciﬁc binding with good
limit of detection for CPXaC. Therefore, these studies provide new
perspectives for using CPXaC as a potential biomarker for highly
sensitive piezoelectric immunosensor for citrus canker detection.Acknowledgments
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